Richard Lehman reviews the latest research in the top medical journals […]
Month: March 2018
Jeffrey Aronson: When I Use a Word . . . Carnitine
Last week I discussed meldonium, which was banned by the World Anti-Doping Agency (WADA) in January 2016 for use by sportsmen and women, because it supposedly increases blood flow and […]
Benjamin Mazer: The dog whistle medicine of the anti-vaccine movement
The vaccine “debate” is the art of not talking about what we are talking about […]
Theodora Bloom and Navjoyt Ladher: Diversity in clinical research and scholarly publishing
It’s International Women’s Day, so we’re all being challenged to think about how far we’ve managed to eliminate gender biases in our work. What’s going on in sexism and diversity […]
Katherine Sleeman: Assisted dying—how safe is safe enough?
We must separate the question of whether assisted dying is morally acceptable from the question of whether it should be legalised […]
Vinay Prasad on the NCCN’s cancer treatment guidelines: The US system needs an audit
What level of evidence should we have before costly, toxic cancer drugs are given to patients? […]
Kieran Walsh: Antibiotic resistance—a role for clinical decision support?
There have been concerns about antibiotic resistance for decades. But concerns have grown in recent years as the problem continues to get worse. Various strategies have been used to address […]
Naren Patel and John Middleton: Brexit must “do no harm” to the public’s health
The government needs to secure in statute its commitment to the public’s continuing health […]
Lieven Annemans: We need to reach a common understanding about real world data
Although real world data can complement data from trials, overly optimistic expectations about its use may lead to a situation of “surreal world data” […]
Richard Smith: Celebrating progress with creating a sustainable NHS
One of the successes of health workers concerned with climate change has been to get climate change framed as a health issue as well as an environmental issue […]